Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health services and systems news

Show

From To
Kenya: Is integrated methadone and HIV care possible?

In Kenya, people who inject drugs have a constant daily battle with poverty and addiction. From waking to sleeping, they need to get money to live. This battle takes time. Their HIV care has to come second to the immediate need to survive. People who inject drugs say that lack of time is the main reason they do not access HIV care.

Published
13 June 2014
From
International HIV/AIDS Alliance
Harm reduction: It's plain humanity

Lord Fowler, who led the development of a pragmatic response to HIV/AIDS in the 1980's in the UK, talks about getting controversial policies through the cabinet, the responses of other countries and the current situation.

Published
13 June 2014
From
You Tube
VIDEO: The Powerful “HIV is Not a Crime” Conference

The most powerful speaker at the recent “HIV is Not a Crime” conference was a man named Kerry Thomas. He held the crowd of more than 150 advocates spellbound for a full twenty minutes although he never took the stage. He spoke by phone from Idaho Correctional Facility, a place he may not be released from until 2038.

Published
13 June 2014
From
My Fabulous Disease
Uganda’s LGBTI Activist and Doctor, Paul Semugoma Awarded 2014 Elizabeth Taylor Human Rights Award

The Elizabeth Taylor Human Rights Award recognizes the efforts of individuals who have achieved major breakthroughs or shown exceptional courage and leadership in their efforts to advocate for human rights in the field of HIV.

Published
13 June 2014
From
Denis Nzioka (blog)
South Africa: Antiretrovirals Credited for TB Decline

South Africa is seeing about 79,000 fewer TB cases annually thanks to increased HIV treatment uptake, according to the latest research from the National Institute for Communicable Diseases (NCID)

Published
13 June 2014
From
Health-e
Glaxo's ViiV Joins J&J's Janssen to Develop Single-Pill HIV Drug

Glaxo’s majority-owned ViiV Healthcare venture is collaborating with Johnson & Johnson’s Janssen unit to test a pill combining ViiV’s Tivicay with Janssen’s Edurant, ViiV said today in a statement. Trials are expected to begin next year, the Brentford, U.K.-based company said.

Published
13 June 2014
From
Bloomberg
Low uptake of HCV treatment in England will lead to substantial disease burden by 2035

Only 3% of patients with chronic hepatitis C virus (HCV) are treated for their infection each year in England, according to research published in the Journal of

Published
13 June 2014
By
Michael Carter
FDA lifts hold on Achillion's hepatitis C drug, shares jump

Achillion Pharmaceuticals Inc said the U.S. Food and Drug Administration allowed it to resume the development of one of its hepatitis C drugs, sovaprevir, lifting a clinical hold that was imposed nearly a year ago. The company's shares soared as much 56 percent to $6.65 on the Nasdaq on Tuesday. Merck & Co's planned acquisition of Idenix Pharmaceuticals, announced on Monday, leaves Achillion as the only unencumbered company developing drugs that block a protein required by the hepatitis C virus to replicate.

Published
11 June 2014
From
Reuters
England: New study reveals the costs of low uptake of hepatitis C treatment

While there would be a financial cost to rapidly increasing treatment rates, the increase is not as great as you might think because the costs of managing undiagnosed and untreated hepatitis C are so high. Currently, we are paying a very high price in terms of lives lost and burden placed on future health care resources.

Published
10 June 2014
From
Public Health England (press release)
Michael Saag: What US health care reform could learn from HIV history

Our health care system is sick, says Alabama AIDS physician Michael Saag, MD, in his memoir, Positive: One Doctor’s Personal Encounters With Death, Life and the U.S. Healthcare System. But the prognosis isn’t fatal. Here, he explains what health care reform could learn from HIV history.

Published
10 June 2014
From
Poz

Filter by country